P. Patriarca

5.0k total citations
73 papers, 3.5k citations indexed

About

P. Patriarca is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P. Patriarca has authored 73 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 22 papers in Infectious Diseases and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Patriarca's work include Influenza Virus Research Studies (30 papers), Respiratory viral infections research (18 papers) and Viral gastroenteritis research and epidemiology (16 papers). P. Patriarca is often cited by papers focused on Influenza Virus Research Studies (30 papers), Respiratory viral infections research (18 papers) and Viral gastroenteritis research and epidemiology (16 papers). P. Patriarca collaborates with scholars based in United States, Switzerland and United Kingdom. P. Patriarca's co-authors include Manon Cox, Peter F. Wright, T. Jacob John, Ruvim Izikson, John J. Treanor, Stephen L. Cochi, Karen L. Goldenthal, Alan P. Kendal, Karen M. Farizo and Roland W. Sutter and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

P. Patriarca

71 papers receiving 3.2k citations

Peers

Countries citing papers authored by P. Patriarca

Since Specialization

Citations

This map shows the geographic impact of P. Patriarca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Patriarca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Patriarca more than expected).

Fields of papers citing papers by P. Patriarca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Patriarca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Patriarca. The network helps show where P. Patriarca may publish in the future.

Co-authorship network of co-authors of P. Patriarca

This figure shows the co-authorship network connecting the top 25 collaborators of P. Patriarca. A scholar is included among the top collaborators of P. Patriarca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Patriarca. P. Patriarca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group 2022 ·Vaccines ·Patricia B. Pavlinac, Elizabeth T. Rogawski McQuade, James A Platts-Mills, Karen L. Kotloff, Carolyn Deal, Birgitte Giersing, Richard Isbrucker, Gagandeep Kang, (unknown), Calman A. MacLennan, P. Patriarca, A. Duncan Steele, Kirsten Vannice	8
2	Analysis of the Risks and Benefits of New Chemical Entities Approved by the US Food and Drug Administration (FDA) and Subsequently Withdrawn From the US Market 2018 ·Therapeutic Innovation & Regulatory Science ·P. Patriarca, (unknown), (unknown)	3
3	Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older 2017 ·New England Journal of Medicine ·Lisa M. Dunkle, Ruvim Izikson, P. Patriarca, Karen L. Goldenthal, Derek Muse, Janice D. Callahan, Manon Cox	180
4	Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial 2011 ·Vaccine ·John J. Treanor, Hana M. El Sahly, James C. King, Irene Graham, Ruvim Izikson, Robert Kohberger, P. Patriarca, Manon Cox	129
5	Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons ≥65 years old 2009 ·Vaccine ·W Keitel, John J. Treanor, Hana M. El Sahly, (unknown), Anthony L. Meyer, P. Patriarca, Manon Cox	48
6	Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months 2009 ·Vaccine ·James C. King, Manon Cox, Keith S. Reisinger, James Hedrick, Irene Graham, P. Patriarca	58
7	FluBlok, a recombinant hemagglutinin influenza vaccine 2008 ·Influenza and Other Respiratory Viruses ·Manon Cox, P. Patriarca, John J. Treanor	126
8	Influenza Pandemic Preparedness Plan for the United States 1997 ·The Journal of Infectious Diseases ·P. Patriarca, Nancy J. Cox	55
9	The Effect of Diarrhea on Oral Poliovirus Vaccine Failure in Brazil 1997 ·The Journal of Infectious Diseases ·Drew L. Posey, (unknown), (unknown), Denise Leite Maia Monteiro, P. Patriarca	47
10	Paralytic Poliomyelitis in Romania, 1984–1992 1994 ·American Journal of Epidemiology ·Peter M. Strebel, (unknown), N Ion-Nedelcu, (unknown), (unknown), Roland W. Sutter, Olen M. Kew, Mark A. Pallansch, P. Patriarca, Stephen L. Cochi	45
11	Evaluation of telephoned computer-generated reminders to improve immunization coverage at inner-city clinics. 1993 ·PubMed ·Paul A. Stehr‐Green, Eugene F. Dini, Mary Lou Lindegren, P. Patriarca	68
12	Paralytic Poliomyelitis in Oman: Association between Regional Differences in Attack Rate and Variations in Antibody Responses to Oral Poliovirus Vaccine 1993 ·International Journal of Epidemiology ·Roland W. Sutter, P. Patriarca, A. J. M. Suleiman, Mark A. Pallansch, Elizabeth R. Zell, Pradeep Malankar, (unknown), (unknown), (unknown)	20
13	Principes de la lutte contre la rougeole 1991 ·Bulletin of the World Health Organization ·FT Cutts, Ralph H. Henderson, C. John Clements, (unknown), P. Patriarca	0
14	Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: Review 1991 ·Clinical Infectious Diseases ·P. Patriarca, Peter F. Wright, T. Jacob John	342
15	Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children 1991 ·The Lancet ·Roland W. Sutter, P. Patriarca, Stephen L. Cochi, Mark A. Pallansch, Olen M. Kew, D. B. Hall, (unknown), Pradeep Malankar, (unknown), A. J. M. Suleiman, (unknown), (unknown), James P. Alexander	69
16	Poliomyelitis in the United States: A Historical Perspective and Current Vaccination Policy 1990 ·Journal of American College Health ·Karen M. Farizo, Stephen L. Cochi, P. Patriarca	2
17	Current Epidemiology of Pertussis in the United States(A. Current Epidemiology of Pertussis)(II. The Eradication of Pertussis: Current Unsolved Epidemiologic, Clinical and Public Health Problems which Impede This Goal)(Clinical Aspects of Acellular Pertussis Vaccines) 1988 ·Sonja S. Hutchins, Stephen L. Cochi, Edward W. Brink, P. Patriarca, Steven G. F. Wassilak, (unknown), Alan R. Hinman	2
18	Comparative results on chloride stress corrosion cracking of steam generator materials in cyclic steam environment 1975 ·Materials performance ·(unknown), P. Patriarca, (unknown), (unknown)	4
19	CONSTRUCTION MATERIALS FOR MOLTEN SALT REACTORS 1964 ·Transactions of the American Nuclear Society ·Alfredo Taboada, W. H. Cook, P. Patriarca	8
20	BONDING OF CERMET-VALVE COMPONENTS TO METALS 1958 ·(unknown), P. Patriarca, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact